![]() |
|
|
Vol. 25, Issue 12, 1379-1382, 1997
Institute for Basic Psychiatric Research, Department of Biological
Psychiatry, Psychiatric Hospital in Aarhus, Aarhus University Hospital
The metabolism of clozapine was studied in vitro using
cDNA-expressed human cytochrome P450 (CYP) enzymes 1A2, 3A4, 2C9, 2C19, 2D6, and 2E1. CYP1A2, 3A4, 2C9, 2C19, and 2D6 were able to
N-demethylate clozapine. N-Oxide formation was
exclusively catalyzed by CYP3A4. CYP2E1 did not metabolize clozapine.
With regard to quantitative relationships, CYP1A2, 2C9, 2C19, and 2D6
displayed KM values ranging from 13 to 25 µM, whereas CYP3A4 had a 5-10 times higher KM value. CYP2C19 and 2D6 had the highest
Vmax values (149-366 mol/hr/mol CYP).
Taking into account the typical relative distribution of amounts of CYP
enzymes in the liver, a simulation study suggested that at therapeutic
concentrations CYP2C19 and CYP3A4 each accounted for about 35% of the
metabolism. At toxic concentrations, the relative importance of CYP3A4
increased.
This article has been cited by other articles:
![]() |
W. V. Zhang, F. D'Esposito, R. J. Edwards, I. Ramzan, and M. Murray Interindividual Variation in Relative CYP1A2/3A4 Phenotype Influences Susceptibility of Clozapine Oxidation to Cytochrome P450-Specific Inhibition in Human Hepatic Microsomes Drug Metab. Dispos., December 1, 2008; 36(12): 2547 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghaznavi, M. Nakic, P. Rao, J. Hu, J. A. Brewer, J. Hannestad, and Z. Bhagwagar Rechallenging With Clozapine Following Neutropenia: Treatment Options for Refractory Schizophrenia Am J Psychiatry, July 1, 2008; 165(7): 813 - 818. [Full Text] [PDF] |
||||
![]() |
P. T. Pollak and S. L. Shafer Teaching Application of Clinical Pharmacology Skills Using Unusual Observations from Clozapine Overdoses J. Clin. Pharmacol., February 1, 2004; 44(2): 141 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. DEQUARDO Modafinil-Associated Clozapine Toxicity Am J Psychiatry, July 1, 2002; 159(7): 1243 - 1244. [Full Text] |
||||
![]() |
M. A. Bruce, S. D. Hall, B. D. Haehner-Daniels, and J. C. Gorski In Vivo Effect of Clarithromycin on Multiple Cytochrome P450s Drug Metab. Dispos., July 1, 2001; 29(7): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schaber, G. Wiatr, H. Wachsmuth, M. Dachtler, K. Albert, I. Gaertner, and U. Breyer-Pfaff Isolation and Identification of Clozapine Metabolites in Patient Urine Drug Metab. Dispos., June 1, 2001; 29(6): 923 - 931. [Abstract] [Full Text] |
||||
![]() |
K. J. Aitchison, M. W. Jann, J. H. Zhao, T. Sakai, H. Zaher, K. Wolff, D. A. Collier, R. W. Kerwin, and F. J. Gonzalez Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice J Psychopharmacol, July 1, 2000; 14(4): 353 - 359. [Abstract] [PDF] |
||||